{"id":"W2083983329","doi":"10.1007/s10637-006-6406-7","title":"A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Mount Sinai Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Nausea; Vomiting; Sarcoma; Soft tissue sarcoma; Internal medicine; Adverse effect; Toxicity; Progressive disease; Surgery; Population; Dosing; Gastroenterology; Phases of clinical research; Chemotherapy; Soft tissue; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001214944,0.0018861,0.002140336,0.0004315893,0.0004675889,0.0009194906,0.00089297,0.00126468,0.003774829],"category_scores_gemma":[0.0007510401,0.0005142986,0.001246536,0.000525538,0.00114022,0.0006962748,0.0003399265,0.002515405,0.001004652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001305231,"about_ca_system_score_gemma":0.002433741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004451155,"about_ca_topic_score_gemma":0.01375438,"domain_scores_codex":[0.9996998,0.00013949,0.000008549999,0.00004430479,0.00002213011,0.00008567593],"domain_scores_gemma":[0.9993966,0.00007283942,0.000094544,0.00004075484,0.00003074518,0.0003645535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8385738,0.0280493,0.005982309,0.0007494303,0.00129167,0.0004844561,0.0002508329,0.003879474,0.02905443,0.0006115599,0.008988122,0.08208457],"study_design_scores_gemma":[0.7794712,0.2048387,0.009198369,0.00003366547,0.000374744,0.0003256727,0.00006344916,0.0009440257,0.001519991,0.0002726016,0.002926518,0.00003111265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899739,0.002574194,0.0004360701,0.001094205,0.0001830196,0.001665208,0.001628784,0.00009376816,0.002350891],"genre_scores_gemma":[0.9843886,0.003075622,0.00133515,0.001245221,0.0001749498,0.00217676,0.00305083,0.00003355271,0.004519347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004451155,"threshold_uncertainty_score":0.01262802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04329356748062302,"score_gpt":0.3666796670381587,"score_spread":0.3233860995575357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}